GALT
Galectin Therapeutics Inc.
$5.07
+$0.35(+7.42%)
45
Overall
40
Value
66
Tech
31
Quality
Market Cap
$307.49M
Volume
470.95K
52W Range
$0.73 - $6.55
Target Price
$6.00
EPS Estimates Overview
| Current Quarter | $-0.11 | Next Quarter | $-0.1 |
| Current Year | $-0.49 | Next Year | $-0.44 |
| QoQ Growth | +9.1% | YoY Growth | +10.2% |
| 3Y EPS CAGR | N/A | Target Price | $6.00 |
| Consensus | Buy | Upside | +18.3% |
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GALT | $5.07 | +7.4% | 470.95K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Galectin Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW